Loading clinical trials...
Loading clinical trials...
A Multi-Center, Open Label, Collaborative Research Study to Treat HRS-AKI Patients With Continuous Terlipressin Infusion
Conditions
Interventions
Terlipressin
Locations
7
United States
California Pacific Medical Center
San Francisco, California, United States
Piedmont Healthcare, Inc
Atlanta, Georgia, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
December 11, 2020
Primary Completion Date
December 27, 2023
Completion Date
December 27, 2023
Last Updated
October 9, 2024
NCT06256432
NCT05309200
NCT05875948
NCT05434286
NCT00089570
NCT01649037
Lead Sponsor
University of Pennsylvania
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions